Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LENVATINIB vs LEVALBUTEROL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LENVATINIB vs LEVALBUTEROL: Safety Overview

Metric LENVATINIB LEVALBUTEROL
Total FAERS Reports 33,766 1,445
Deaths Reported 4,449 52
Death Rate 13.2% 3.6%
Hospitalizations 19,975 145
Average Patient Age 65.4 yrs 54.6 yrs
% Female Patients 55.8% 70.8%
FDA Approval Date Feb 13, 2015 Apr 26, 2013
Manufacturer Eisai Inc. Actavis Pharma, Inc.
Route ORAL ORAL
Marketing Status Prescription Discontinued